The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Targeting Breast Cancer Stem Cells
Open accessAbstract
There is increasing evidence that many cancers, including breast cancer, contain populations of cells that display stem-cell properties. These breast cancer stem cells, by virtue of their relative resistance to radiation and cytotoxic chemotherapy, may contribute to treatment resistance and relapse. The elucidation of pathways that regulate these cells has led to the identification of potential therapeutic targets. A number of agents capable of targeting breast cancer stem cells in preclinical models are currently entering clinical trials. Assessment of the efficacy of the agents will require development of innovative clinical trial designs with appropriate biologic and clinical end points. The effective targeting of breast cancer stem cells has the potential to significantly improve outcome for women with both early-stage and advanced breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Sensing radiosensitivity of human epidermal stem cells
Rachidi, W., Harfourche, G., Lemaı̂tre, G., Amiot, F., Vaigot, P., & Martin, M. T. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.007 · Cited by 65
Myelotoxicity From Chemotherapy
Daniel, D. B., & Crawford, J. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.11.003 · Cited by 64
Perrimon, N., Friedman, A. A., Mathey-Prévôt, B., & Eggert, U. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.006 · Cited by 48
Statins to reduce breast cancer risk: A case control study in U.S. female veterans
Kochhar, R., Khurana, V., Bejjanki, H. R., Caldito, G. C., & Fort, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.514 · Cited by 41
Targeted therapies in multiple myeloma
Kastritis, E., Charidimou, A., Varkaris, A. S., & Dimopoulos, M. A. (2009) · Targeted Oncology · doi:10.1007/s11523-008-0102-9 · Cited by 36
Expanding the arsenal: Metformin for the treatment of triple-negative breast cancer?
Jiralerspong, S., Gonzalez-Angulo, A. M., & Hung, M. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9502 · Cited by 32
Getting to the Root of BRCA1-Deficient Breast Cancer
Ginestier, C., Liu, S., & Wicha, M. S. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.08.007 · Cited by 27
Self-citation
Cited by
DeRose, Y. S., Wang, G., Lin, Y.-C., Bernard, P. S., Buys, S. S., Ebbert, M. T. W., Factor, R., Matsen, C., Milash, B. A., Nelson, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2454 · Cited by 1,002
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
Self-renewal as a therapeutic target in human colorectal cancer
Kreso, A., van Galen, P., Pedley, N. M., Lima-Fernandes, E., Frelin, C., Davis, T., Cao, L., Baiazitov, R., Du, W., Sydorenko, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3418 · Cited by 500
Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V, Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 421
Metadata
- Authors
- Liu, S., & Wicha, M. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-09-01
- Volume
- 28
- Issue
- 25
- Pages
- 4006-4012
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2170816578
- Cited by
- 356
- References
- 207
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.